ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma-Reference-Cited by-同舟云学术

ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma

Published:2013-12 Issue:6 Volume:59 Page:1264-1270
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ziol Marianne,Sutton Angela,Calderaro Julien,Barget Nathalie,Aout Mounir,Leroy Vincent,Blanc Jean-Frédéric,Sturm Nathalie,Bioulac-Sage Paulette,Nahon Pierre,Nault Jean-Charles,Charnaux Nathalie,N’Kontchou Gisèle,Trinchet Jean-Claude,Delehedde Maryse,Seror Olivier,Beaugrand Michel,Vicaut Eric,Ganne-Carrié Nathalie

Publisher

Elsevier BV

Subject

Hepatology

Reference28 articles.

1. Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities;Trinchet;Hepatology,2011

2. Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma;Villanueva;Gastroenterology,2011

3. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy;Imamura;J Hepatol,2003

4. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma;Kumada;Hepatology,2007

5. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation;Llovet;Hepatology,1999

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EpCAM, Ki67, and ESM1 Predict Hepatocellular Carcinoma Recurrence After Liver Transplantation;Applied Immunohistochemistry & Molecular Morphology;2023-09-04

2. Understanding the causes of recurrent HCC after liver resection and radiofrequency ablation;Expert Review of Anticancer Therapy;2023-04-20

3. ESM-1 Mediates Cell Progression in Clear Cell Renal Cell Carcinoma by Affecting Wnt/β-Catenin Signalling Pathway;Archivos Españoles de Urología;2023

4. Higher Serum Endothelial-Specific Molecule-1 (ESM-1/Endocan) Levels are Associated with Poor Pathological Outcomes in Primary Bladder Cancer: A Non-randomized, Prospective, Case-Control Study;Archivos Españoles de Urología;2023

5. Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer;Frontiers in Endocrinology;2022-11-28